Business
DarioHealth Partners with National Group Benefits Platform
New partnership makes Dario's full suite of digital therapeutics available to National Group Benefits Platform's large population of employers NEW YORK, Nov.
About this update from Dariohealth Corp.
[{"type":"text","content":"New partnership makes Dario's full suite of digital therapeutics available to National Group Benefits Platform's large population of employers\n\n\nNEW YORK, Nov. 3, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today a new strategic partnership with a leading national benefits administrative platform (\"Benefits Platform\"), to provide its full suite of integrated digital therapeutic and health solutions to a wide range of employers, beginning in January of 2022.\nThe Benefits Platform will offer Dario's full suite of integrated chronic condition solutions for diabetes, pre-diabetes, hypertension, weight management, musculoskeletal and behavioral health to individuals and organizations through its platform. Dario's proven ability to drive behavior change for better health outcomes and lower costs aligns with the Benefits Platform product strategy of delivering quality benefits at a lower price to its customers. \nDario also supports the Benefits Platform clients with diverse populations through an AI-driven journey engine crafting a single user journey across its suite of easy-to-use digital tools, available in 7 languages, to provide the same benefits experience for all members.\n\"This new partnership creates another avenue to expand our visibility with employers and other organizations that need scalable, proven chronic condition solutions to support large populations. Dario and the Benefits Platform value some of the same product qualities, such as ease of use and high return on value, making this a natural fit for expansion of our strategic growth partners,\" said Rick Anderson, President and General Manager North America. \nAbout DarioHealth Corp.\nDarioHealth Corp. (Nasdaq: DRIO) is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. DarioHealth offers one of the most comprehensive digital therapeutics solutions on the market - covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform.\nDario's next-generation, AI-powered, digital therapeutic platform supports more than just an individual's disease. Dario provides adaptive, personalized experiences that drive behavior ch...